COVID-19
Conditions
Interventions
A trial longitudinal, cohort study was conducted in two groups with or without COVID-19 influenza-like symptoms that received the homeopathic medicine. Total of 51 families (128 participants) used thr
HP4.018.189.437
Sponsors
Faculdade de Farmácia da Universidade Federal do Rio de Janeiro
Faculdade de Farmácia da Universidade Federal Fluminense
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Women and men aged 18 years or older with or not COVID-19 influenza-like symptoms were included in this study
Exclusion criteria
Exclusion criteria: The exclusion criterion was a severe acute respiratory syndrome that leads to hospitalization by primary care teams
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome expected 1: It is expected to find a decrease in the number or absence of symptoms similar to that of coivd-19 in the period of two months, verified using the McNemar method, based on the finding of a significance level of at least 95% confidence.;Outcome found 1: No statistically significant difference related to the severity of illness in the previous sick and health groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome expected 2: It is expected to find a decrease in the number or absence of visits to emergency services, number of hospitalizations and presence of adverse events in the period of two months, analyzed by the t-student c test, based on the verification of a significance level of at least least 95% confidence. ;Outcome found 2: The secondary outcome showed that a high percentage of the participants (98.03%) reported having had general health symptoms' improvements (84.31%) and none reported adverse events. | — |
Countries
Brazil
Contacts
Public ContactAdriana Oliveira
Faculdade de Farmácia da Universidade Federal do Rio de Janeiro
Outcome results
None listed